Mitsubishi Tanabe Builds its Presence in North America
By Taskin Ahmed
Pharma Deals Review: Vol 2008 Issue 98 (Table of Contents)
Published: 30 Jul-2008
DOI: 10.3833/pdr.v2008.i98.154 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
In its quest to expand its overseas operations in the field of chronic kidney disease, Mitsubishi Tanabe licensed Cytochroma’s vitamin D analogue, CTA018 , and acquired a stake in the Canadian company...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018